Completed OBSERVATIONAL NCT05853315

BCC Excision Revisited

Long-term Results After Surgical Basal Cell Carcinoma Excision in the Eyelid Region: Revisited

Sponsor: Medical University of Vienna

Conditions Basal Cell Carcinoma Eye Cancer Eye Diseases

Interventions Surgery

Updated 3 times since 2023 Last updated: May 14, 2023 Started: Nov 12, 2019 Primary completion: Apr 1, 2023 Completion: May 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Basal Cell Carcinoma and Eye Cancer and is currently completed. Medical University of Vienna leads this study, which shows 3 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2023 — Jul 2024 [monthly]

Completed

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria